ReversingLabs Identifies Novel ML Malware Hosted on Leading Hugging Face AI Model Platform
Dubbed “nullifAI,” a Tactic for Evading Detection in ML Models Targeted Pickle…
New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) --…
GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
GENFIT signs royalty financing deal with HealthCare Royalty (HCRx) providing up to…
ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders Meeting
January 27, 2025 09:31 ET | Source: Oryzon Genomics, S.A. Aimed at…
TriNetX’s Founding CEO Announces Plans to Step Down
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's…
TriNetX’s Founding CEO Announces Plans to Step Down
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's…
TriNetX’s Founding CEO Announces Plans to Step Down
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's…
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu
CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- DIOSynVax, a…
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025 16:05 ET | Source: Relay Therapeutics, Inc. CAMBRIDGE, Mass.,…
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
January 06, 2025 16:30 ET | Source: Generation Bio Co. Novel programs…